Search
SOLACI Congress
HomeFilePeripheral vascular disease

Peripheral vascular disease

View Category

Antiplatelet

Cilostazol in Diabetic Patients with Endovascular Peripheral Revascularization: One Step Beyond Symptom Improvement

In patients with peripheral vascular disease (PVD), the presence of diabetes has been significantly associated with increased...
solaci -
Learn More
Peripheral vascular disease

Renal Denervation is Safe and Reduces Blood Pressure and Medication

We are well aware of the multifactorial nature of hypertension, as well as the fact that it...
solaci -
Learn More
Coronary disease

Low vs High Dose Drug Coated Balloons in Femoropopliteal Territory

The use of drub coated balloons (DCB) in the treatment of femoropopliteal artery disease has grown. Studies...
solaci -
Learn More
Infrapatellar

TCT 2023 The LIFE-BTK Trial

This was a randomized study including 261 patients treated with infrapatellar percutaneous transluminal angioplasty.173 of these patients...
solaci -
Learn More
Highlighted Presentations

SOLACI-SBHCI 2023 | Tips and Tricks with Renal Denervation – Dr. María Sanalí Paiva

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. María...
solaci -
Learn More
Highlighted Presentations

SOLACI-SBHCI 2023 | Insights from the LATAM Peripheral Registry – Dr. Maximiliano Rossi

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Maximiliano...
solaci -
Learn More
Highlighted Presentations

SOLACI-SBHCI 2023 | Acute pulmonary embolysmworkflow: Patient Screening & Endovascular treatment indications – Dr. João Luiz Frighetto

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. João...
solaci -
Learn More
Aorta

SOLACI-SBHCI 2023 | AORTIC ANEURYSM FROM THE GUIDELINES TO THE REAL WORLD – Dr. Felix Damas de los Santos

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Felix...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Dr. Omar Tupayachi - 0
Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

Dr. Omar Tupayachi - 0
The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Dr. Omar Tupayachi - 0
Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...

Institutional News

Watch our event on Evidence and Controversies of Renal Denervation in 2025

solaci - 0
You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

solaci - 0
The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

Uruguay Sessions 2025 | Young Interventional Cardiologists Contest

solaci - 0
Call for Case Submission LI SOLACI Regional Sessions – 16° Southern Cone  It is with great pleasure that we hereby invite all young Latin American cardiologists...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy